Name: Professor Hal Drakesmith
MRC Molecular Haematology Unit
http://www.imm.ox.ac.uk/alexander-hal-drakesmith-2
Events this person is hosting:
Monday 8 March 2021
RANKL-bone loss, breast cancer and pregnancy (VIA ZOOM)
Date: 8 March 2021, 16:00 - 17:00
Speaker
:
Prof Josef Penninger (Life Sciences Institute, University of British Columbia, Canada)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Organiser:
Kate Forbes (MRC WIMM)
Host:
Professor Hal Drakesmith (MRC Molecular Haematology Unit )
Wednesday 17 November 2021
Friend or foe: lipid metabolism in tailoring macrophage immune responses in tumors
Date: 17 November 2021, 13:30 - 14:30
Speaker
:
Professor Ping-Chih Ho (Department of Fundamental Oncology, University of Lausanne; Ludwig Institute for Cancer Research, Switzerland)
Organiser:
Anne Farmer (University of Oxford, NDM Experimental Medicine, RDM Investigative Medicine Division)
Host:
Professor Hal Drakesmith (MRC Molecular Haematology Unit )
Tuesday 28 February 2023
Mechanism-based therapies for beta-haemoglobinopathies
Date: 28 February 2023, 15:00 - 16:00
Speaker
:
Professor Mitch J. Weiss (Chairman, Department of Hematology, St. Jude Children’s Research Hospital, Memphis, USA)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Organiser:
Professor Hal Drakesmith (MRC Molecular Haematology Unit )
Hosts:
Professor Hal Drakesmith (MRC Molecular Haematology Unit ),
Professor Tom Milne (Weatherall Institute of Molecular Medicine, University of Oxford)
Events this person is organising:
Tuesday 28 February 2023
Mechanism-based therapies for beta-haemoglobinopathies
Date: 28 February 2023, 15:00 - 16:00
Speaker
:
Professor Mitch J. Weiss (Chairman, Department of Hematology, St. Jude Children’s Research Hospital, Memphis, USA)
Venue: MRC Weatherall Institute of Molecular Medicine, Headington OX3 9DS
Organiser:
Professor Hal Drakesmith (MRC Molecular Haematology Unit )
Hosts:
Professor Hal Drakesmith (MRC Molecular Haematology Unit ),
Professor Tom Milne (Weatherall Institute of Molecular Medicine, University of Oxford)